Reply to "Risk reduction of Parkinson's disease by caffeinated beverage consumption".

MLA

Belvisi, Daniele, et al. “Reply to ‘Risk Reduction of Parkinson’s Disease by Caffeinated Beverage Consumption.’” Parkinsonism & Related Disorders, vol. 103, Oct. 2022, pp. 15–16. EBSCOhost, https://doi.org/10.1016/j.parkreldis.2022.08.010.

APA

Belvisi, D., Costanzo, M., Pellicciari, R., Modugno, N., Nicoletti, A., Fabbrini, G., Tinazzi, M., Defazio, G., & Berardelli, A. (2022). Reply to “Risk reduction of Parkinson’s disease by caffeinated beverage consumption.” Parkinsonism & Related Disorders, 103, 15–16. https://doi.org/10.1016/j.parkreldis.2022.08.010

Chicago

Belvisi, Daniele, Matteo Costanzo, Roberta Pellicciari, Nicola Modugno, Alessandra Nicoletti, Giovanni Fabbrini, Michele Tinazzi, Giovanni Defazio, and Alfredo Berardelli. 2022. “Reply to ‘Risk Reduction of Parkinson’s Disease by Caffeinated Beverage Consumption.’” Parkinsonism & Related Disorders 103 (October): 15–16. doi:10.1016/j.parkreldis.2022.08.010.